Concepedia
Anticancer Research · 2018 · 12 citations · 16 references
Open access
Methadone could act as a chemosensitizer in the future treatment of advanced bladder cancer. Further research is needed to identify the underlying molecular mechanisms.
16
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
Gilbert Chu · Journal of Biological Chemistry · 1994 · 655 citations · Full text
Molecular Biology, Cell Death, Anticancer Drug Cisplatin +16
Switching From Morphine to Methadone to Improve Analgesia and Tolerability in Cancer Patients: A Prospective Study
Sebastiano Mercadante, Alessandra Casuccio, Fabio Fulfaro et al. · Journal of Clinical Oncology · 2001 · 248 citations
Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer
Dylan M. Zylla, Brett L. Gourley, Derek Vang et al. · Cancer · 2013 · 191 citations · Full text
Mor Expression, Urology, Health Sciences +13
The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine
Kim Kristensen, Christian Broen Christensen, Lona Louring Christrup · Life Sciences · 1994 · 190 citations
Molecular Pharmacology, Methadone Stereoisomers, Functional Selectivity +10
Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells
Hee Jun Cho, Jin Koo Kim, Kwang Dong Kim et al. · Cancer Letters · 2005 · 153 citations
Urology, Oncology, Genitourinary Cancer +8